Drug firm collusion ‘cost the NHS millions of pounds’

Four pharmaceutical firms have been accused of illegally colluding to restrict the supply of an anti-nausea tablet, driving the price paid for it by the NHS up by 700%.

An investigation by the Competition and Markets Authority (CMA) found that the cost of the drug prochlorperazine rose from £6.49 per pack to £51.68, following an agreement between suppliers not to compete. The drug is commonly used by cancer patients undergoing chemotherapy. Alliance, one of the named companies, denied the allegations.

In a statement of objections, the CMA says that between 2013 and 2018, the annual cost of 3mg dissolvable prochlorperazine tablets increased from approximately £2.7m to £7.5m, even though the NHS dispensed fewer packs during that period.

Full story on BBC News, 23 May 2019.

Sign up for the latest stories and investigations

Something went wrong. Please check your entries and try again.